Joseph Jimenez Explained

Joseph Jimenez
Nationality:American
Alma Mater:Stanford University
University of California, Berkeley[1]
Occupation:Former CEO of Novartis

Joseph Jimenez is the former CEO of the Swiss pharmaceutical company Novartis.[2]

Education

Jimenez earned a bachelor's degree from Stanford University in 1982, and an MBA from Berkeley's Haas School of Business in 1984.[3]

Career

Early career

Jimenez began his career at Clorox before joining ConAgra Foods.[4] [5] [6] Prior to joining Novartis, he was head of H. J. Heinz Company's North American business from 2002 to 2006. He was also a non-executive director of AstraZeneca from 2002 to 2007, as well as an advisor for the Blackstone Group.[5]

Novartis

Jimenez joined Novartis in 2007 as Division Head of Novartis Pharmaceutical and was named CEO in 2010[7] by his predecessor and Chairman Daniel Vasella.[8]

During his time at Novartis, Jimenez increasingly applied standard business metrics to pharma cash flow, purchasing and competitive bidding, confident that his experience in consumer goods would help to realize improvements in Novartis' operations. His cost-cutting moves, focused mostly on marketing and administration, came steadily, with more than a billion cut in 2010, and even more than that in 2011.[9]

Jimenez joined the board of directors at General Motors on June 9, 2015[10] [11]

Jimenez resigned from Novartis, leaving in February 2018, and was succeeded by Vasant Narasimhan.[12] [13]

He joined the Board of Directors of San Francisco biotech startup uBiome in September 2018 and stepped down in April 2019 to start the biotech venture fund Aditum Bio.[14]

Jimenez also has served on the Board of Directors of Procter & Gamble since 2018, where he is lead independent director.[15] He also serves as Chairman of Century Therapeutics, an iPSC derived allogeneic cell therapy company, and is on the Board of Graphite Bio, a gene therapy company.[16] [17]

External links

Notes and References

  1. Web site: Novartis Foundation - Home . 2012-03-11 . 2015-10-04 . https://web.archive.org/web/20151004094148/http://www.novartisfoundation.org/platform/content/element/4381/bio_jimenez_e_final.pdf . dead .
  2. News: Fix the Problem, and Not Just the Symptoms. New York Times. 8 October 2011. 22 May 2013. Bryant. Adam.
  3. Web site: Joseph Jimenez MBA. Businessweek. 22 May 2013.
  4. Web site: Joseph Jimenez - Forbes . https://web.archive.org/web/20090402063203/http://people.forbes.com/profile/joseph-jimenez/12367 . dead . April 2, 2009 . People.forbes.com . 2012-04-18 . 2012-08-02.
  5. Web site: P&G investors wish for CEO Joe Jimenez as outgoing Novartis chief joins board. 2021-07-27. FiercePharma. 18 December 2017 . en.
  6. Web site: Buck. Jonathan. Novartis CEO Writes a Prescription for the Swiss Drug Giant's Success. 2021-07-27. online.barrons.com. en-US.
  7. Web site: Joseph Jimenez - The 25 most influential people in biopharma today. 7 February 2012 . Fierce Biotech. 22 May 2013.
  8. Web site: Greil . Anita . Vasella's Impeccable Timing - The Source - WSJ . Blogs.wsj.com . 2010-01-26 . 2012-08-02.
  9. Web site: Joseph Jimenez - The 25 most influential people in biopharma today - FierceBiotech. www.fiercebiotech.com. 7 February 2012 .
  10. Web site: About GM: Joseph Jimenez . dead . https://web.archive.org/web/20150906055830/http://www.gm.com/company/aboutGM/board_of_directors0/joseph_jimenez.html . 2015-09-06 . 2023-11-07.
  11. Web site: 2017-12-18 . P&G investors wish for CEO Joe Jimenez as outgoing Novartis chief joins board . 2023-11-07 . Fierce Pharma.
  12. Web site: Novartis CEO Jimenez to Quit, Giving Reins to Harvard Doctor. Bloomberg.com. Bloomberg Technology. 5 September 2017. 4 September 2017.
  13. News: Roland. Denise. 2017-09-04. Novartis CEO to Step Down in January. en-US. Wall Street Journal. 2020-05-07. 0099-9660.
  14. Web site: Al Idrus . Amirah . Biotech Novartis alums Jimenez, Fishman unveil their next act: Aditum Bio . Fierce Biotech . 2 November 2020 . Questex . Nov 3, 2020.
  15. Web site: 2017-12-18 . P&G investors wish for CEO Joe Jimenez as outgoing Novartis chief joins board . 2023-11-07 . Fierce Pharma.
  16. Web site: 2021-05-05 . Century Therapeutics Expands Board of Directors with Key Appointments . 2023-11-07 . B10Space.
  17. Web site: Graphite Bio Inc . 2023-11-07 . Bloomberg.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Joseph Jimenez".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.